Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Suman Majumdar, Associate Professor and Chief Health Officer - COVID and Health Emergencies, Burnet Institute

Could antivirals reduce your risk of long COVID? Where the research is up to on prevention and treatment

Bricolage/Shutterstock

Evidence is continuing to accumulate on the burden and frequency of chronic effects after a COVID infection, which fall under the umbrella term “long COVID”.

At least 5%–10% of people who contract COVID experience long COVID. This can include symptoms (for example, fatigue, brain fog and breathlessness) or conditions (for example, heart conditions, neurological conditions and diabetes) after the initial infection that may be persisting, new or relapsing.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.